tricision

Beijing, China · Founded 2015 · Privately Held (backing)

Developer of research and product and production technology platform designed for messenger ribonucleic acid (mRNA) nucleic acid drugs. tricision is based in Beijing, China and was founded in 2015.

Last price · $/share
—
Implied valuation
—
Total raised
—
Last round
—
Valuation — not yet established

No valuation for tricision is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised and the funding record below are the closest available signals.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of tricision with a free account
  • ·Watch tricision: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

tricision funding history

No rounds on record

No funding rounds for tricision are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

How tricision's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For tricision, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →